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Abstract
Polypharmacy has now increasingly come into focus as
the recipient of healthcare in old age worldwide. In
elderly it is associated with frequent adverse drug
reactions (ADRs) and drug-drug interactions resulting in
significant morbidity. Geriatrics is still an emerging
specialty in South Asia, especially in Pakistan, where
multiple reasons for polypharmacy exist. An extensive
literature review of articles using key words like
'polypharmacy,' 'elderly' was conducted. The recently
updated Beers Criteria of classification of inappropriate
drugs in the elderly was reviewed in detail. Articles of
relevance to polypharmacy and evaluation of guidelines
for appropriate interventions to minimise inappropriate
drug prescribing were also reviewed. Commonly
prescribed drugs like psychotropic, cardiovascular, non-
steroidal anti-inflamanatory drugs (NSAIDs) and oral
hypoglycaemics can cause significant adverse events
when prescribed to the elderly.
Primary care physicians may use evidence based non-
pharmacological interventions which may be appropriate
to use in selected cases. Drugs can affect quality of life and
morbidity in the elderly. A basic understanding of ageing
physiology and pharmacology along with a step-wise
approach to prescribing in the elderly maybe helpful in
minimising iatrogenic complications of commonly used
drugs in this age group.
Keywords: Polypharmacy, Elderly, Adverse drug
reactions, Inappropriate prescribing.
Introduction
Polypharmacy, defined as the use of five drugs or more,
has now increasingly come into focus as the recipient of
healthcare age worldwide. The elderly, with greater
number of co-morbidities, tend to consume more
medications. In the US, about one-fifth of all prescriptions
are written for patients 65 years and older.1 Drugs tend to
behave differently in the elderly compared to the non-
elderly patients. Ageing brings about several changes in
the functioning of organ systems which in turn affect
drug behaviour and metabolism. Prolonged drug half-
lives, adverse drug reactions (ADRs) and drug-drug
interactions thus become more frequent and often result
in significant morbidity in the elderly. A meta-analysis
reported that elderly patients were two times more likely
to get hospitalised due to an ADR than non-elderly
patients.2 An Australian study reported a rising number of
ADRs with approximately 30% in 2003.3 Inappropriate
medications were prescribed to one-third of the elderly.4
National health surveillance data identified inadvertent
high drug dosing as a cause of hospitalisation in almost
66% of the elderly.5 A study from India cited 7% of
hospital admissions in the elderly were related to an ADR.6
Although Western medical literature has extensive
literature on polypharmacy in the elderly, studies in the
eastern hemisphere are scarce. Geriatrics is still an
emerging specialty in this region where the care of an
aged individual is still not clearly understood. Most of the
elderly are cared for by non-geriatric physicians and
comprehensive geriatric assessment and care is limited.
There are multiple reasons for polypharmacy in Pakistan.
Elderly patients are often treated by multiple healthcare
providers, all prescribing medications individually.
Physicians also tend to over-prescribe at times.7 Patients
often indulge in self-medication in an environment where
drugs can be easily purchased over the counter. Physician
practice may further perpetuate inappropriate drug use,
e.g. benzodiazepine usage initiated via physician
prescription was reported in almost half of subjects in a
study.8 This situation appears to be alarmingly similar to
elderly patients in Pakistan where a recent study on
delirium cited a 39% usage of psychoactive drugs in
patients 65 and older.9
As the medical community in this part of the world begins
to manage an increasing population of aged patients, the
need to understand the role of polypharmacy, the
dissimilarity of drug behaviour in the elderly, and risk-
benefit ratio of each drug prescribed to an older
individual becomes important for the provision of quality
healthcare to this growing section of our population. 
The aim of this article is to enhance awareness of
appropriate prescribing in the elderly based on recent
evidence, especially for primary care physicians and non-
geriatric specialists. 
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Methods
A thorough literature search was conducted using
PubMed and Google Scholar to select articles from 2000
till 2012 using key words like polypharmacy, geriatric
patients, elderly care, Beer's criteria, inappropriate
prescribing and adverse drug events. Key phrases like
"oral hypoglycaemic drugs and elderly" were also used to
search articles for specific drugs. 
A literature search from Asia was also done through the
Index Medicus for South East Asia region (IMSEAR) and
PakMediNet, a Pakistani medical journal database, to
identify regional articles.
Thousands of citations were found during the initial
literature search from which 70 most relevant articles
were reviewed in detail. From the regional search, only a
handful of articles were available10-12 of which none was
found in PakMediNet. 
Some older articles which were historically relevant to
polypharmacy and inappropriate prescribing were
included in this review. 
Evidence-based non-drug interventions, and other
interventions to minimise inappropriate prescribing were
reviewed and included as well.
Discussion
In 1991, inappropriate prescribing in the elderly was first
investigated in detail by Mark Beer who established the
Beer's criteria of drugs that were likely to cause more harm
than benefit when prescribed to the elderly.13 His list
included psychoactive drugs of various classes like anti-
depressants, sedatives, anti-psychotics, NSAIDs; all
included after employing a panel of experts working
through the Delphi method. In 2012 the American Geriatric
Society revised and updated the Beer's list, dividing drugs
into three separate categories.14The first category included
drugs known to cause potential adverse events when
prescribed to the elderly and hence avoidance is strongly
advised. The second category included drugs that may
cause potential drug-drug interaction or harm when given
to patients with certain co-morbidities. The third category
included drugs that should be prescribed with caution as
they have the potential of causing adverse reactions as
well; maybe used, however, if no other alternatives existed.
Psychoactive Medications
Psychoactive drugs have been associated with a 2.5 times
decline in ability to perform daily activities in the elderly.15
Of note in our setting are benzodiazepines which are very
commonly prescribed and often self-prescribed8 for sleep
induction. Other studies have also cited frequent use of
benzodiazepines in the elderly.16,17 One study identified up
to 14% adverse drug events related to benzodiazepine use.18
Altered pharmacokinetics and pharmacodynamics in ageing
make both short-acting and long-acting benzodiazepines
risk factors for falls and memory loss in the elderly.19-21
A systematic review showed anti-depressants, especially
tricyclic antidepressants and antipsychotics, to be a factor
in falls.22 It reported a five-time increased risk of falls with
tricyclic antidepressant use.
Drugs with anti-cholinergic properties are common culprits
causing confusion, urinary retention, constipation etc.
These include tricyclic anti-depressants, certain selective
serotonin reuptake inhibitors (SSRIs), and commonly self-
prescribed anti-histamines. Anti-spasmodic and anti-
motility agents also fall into this category on account of
their strong anti-cholinergic properties.
Tricyclic anti-depressants have multiple therapeutic uses
e.g. in depression, insomnia, chronic pain, neuropathic
pain and, therefore, deserve special mention as their anti-
cholinergic properties are often not taken into
consideration while prescribing to the elderly.
Physicians, therefore, need to weigh the risks and benefits
of using psychoactive drugs for each patient on an
individual basis and familiarise themselves with evidence-
based non-pharmacological methods for insomnia and
behavioural symptoms before prescribing these
medications whenever possible.23-25
Cardiovascular Drugs
The South Asian population has a greater burden of
hypertension.26 With age-related arteriosclerosis, rates of
isolated systolic hypertension are high in the elderly,27
making anti-hypertensives a frequent addition to their drug
list. Commonly prescribed anti-hypertensive drugs,
especially angiotensin converting enzyme (ACE) inhibitors
and alpha blockers are linked to syncope and orthostatic
hypotension in the elderly.14Diuretics have been implicated
in falls16 and are more likely to cause hyponatraemia in older
vs. younger patients due to altered renal function. An Italian
study identified diuretics to be causing 10% of
hospitalisations because of an adverse event.28
The changing pharmacokinetics in the elderly, combined
with altered physiology of the cardiovascular and renal
system, make the elderly more vulnerable to the side
effects of common anti-hypertensive agents, including
calcium channel blockers especially those suffering from
co-morbids like heart failure or prior syncope.14 Calcium
channel blockers were cited as causing 9% of
hospitalisations due to an adverse event in one study.28
Using reduced drug dosages29 and slow drug titration
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based on therapeutic response of the patient may help
mitigate serious adverse events. 
Primary care physicians also need to know that drug-drug
interactions are more likely with use of anti-arrhythmic
drugs.30 Risk-benefit ratio of such drugs needs to be
weighed carefully before prescribing.
NSAIDS
Age-related wear and tear of the joints often leads to
chronic pain for which NSAIDs are commonly prescribed
by primary care physicians. As with other drugs,
tolerability of these drugs diminishes with age, often
leading to gastric and duodenal ulcers which are on the
rise in the elderly.31 NSAID use also quadruples the risk of
gastrointestinal bleeding in the elderly.32 Aspirin and
NSAIDs were also accounted for about 30% of ADRs
causing hospitalisations in one study.28
Lower dosages and judicious selection of the type of
NSAID and screening of risk factors prior to the start of
treatment is advised.22 In addition, the use of topical
NSAIDs is now also recommended for reduction of pain
and inflammation of osteoarthritis.33
Other drugs
Statins are added to reduce cardiovascular risk in the
elderly who often have co-morbidities like diabetes and
hypertension. While the risk reduction is important,
polypharmacy is a key factor implicated in increasing risk
of myopathy, especially in the elderly who lose muscle
mass with ageing and have declined hepatic function. In
addition, risk of myopathy is dose-dependent. Another
caveat is prescribing statins to patients 80 years and older,
in whom benefits of medicating are still unclear and may
vary from patient to patient.34-36
With the rapidly rising burden of diabetes in developing
countries37 oral hypoglycaemic drugs deserve a special
mention as well. Long-acting sulphonylureas have been
implicated in prolonged hypoglycaemia due to their
reduced metabolism in the elderly.38 Short-acting
sulphonylureas are a safer option.
In addition to awareness of adverse effects of commonly
prescribed drugs, it is also important that other therapeutic
considerations while caring for the elderly is the need to
apply strategies of appropriate prescribing to reduce the
burden of iatrogenic complications due to non-judicious
drug dispensing. Several options have been proposed:
The Cochrane review suggests that involving pharmacists
in monitoring drugs dispensed to the elderly may have a
role in identifying drugs of concern and mitigate
inappropriate prescribing.39 Another review suggested a
role of educational strategies in improving prescribing
practices in nursing homes.40 A concrete framework is
provided by a recent article which describes a step-wise
approach to addressing the problem of inappropriate
prescribing in the elderly, starting from a complete listing
of medications used to a detailed benefit analysis of the
drug to be dispensed and continued monitoring of
medications that are prescribed by a single care
provider.41 Literature does cite that the higher the
number of providers, the more likely the incidence of
polypharmacy and subsequently an adverse drug event.
This study also cited that the presence of four to five
chronic health conditions increased the risk of an adverse
drug event two-fold.42
A few key points, therefore, to remember are that
complexity of care of an elderly patient not only lies in
dealing with their co-morbids but also an awareness of how
drugs can affect quality of life and morbidity in this age
group. A simple but detailed review of medications (both
prescribed and over-the-counter), reduced drug dosing,
weighing the risk-benefit ratio of each drug, awareness of
drug interactions and ongoing surveillance of medications
may help the primary care providers to provide better
quality of care to their elderly patients. One would do well to
be familiar with basic ageing physiology and pharmacology;
consider possible drug interactions before prescribing;
consider risk-benefit ratio before prescribing; start with
reduced 1/2 to 1/3 of regular adult dosage and gradually
increase if needed; monitor patient carefully for adverse
reactions due to drug or drug interactions; and perform a
detailed drug review at every patient visit.
Conclusion
Polypharmacy is a common occurrence in elderly patients
and may at times cause considerable morbidity in the life of
an aged patient. The importance of judicious prescribing
alligned with a basic understanding of ageing physiology
and pharmacology is necessary for primary care physicians
to adopt in their practice while caring for the aged. 
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